Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases

Anesthesiology. 2003 Apr;98(4):1007-11. doi: 10.1097/00000542-200304000-00030.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Carcinoid Tumor / secondary*
  • Carcinoid Tumor / therapy*
  • Chemoembolization, Therapeutic / adverse effects*
  • Female
  • Flushing / prevention & control*
  • Hemodynamics / drug effects
  • Hormone Antagonists / therapeutic use*
  • Humans
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy*
  • Malignant Carcinoid Syndrome / drug therapy*
  • Middle Aged
  • Serotonin / blood
  • Serotonin / metabolism*
  • Somatostatin / therapeutic use*

Substances

  • Hormone Antagonists
  • Serotonin
  • Somatostatin